Χώρα: Αυστραλία
Γλώσσα: Αγγλικά
Πηγή: Department of Health (Therapeutic Goods Administration)
tibolone, Quantity: 2.5 mg
Southern Cross Pharma Pty Ltd
Tablet, uncoated
Excipient Ingredients: magnesium stearate; mannitol; lactose monohydrate; potato starch; ascorbyl palmitate
Oral
28 tablets, 84 tablets
(S4) Prescription Only Medicine
- Short-term treatment of symptoms resulting from the natural or surgical menopause in postmenopausal women.,- Second line therapy for the prevention of bone mineral density loss in postmenopausal women at high risk of future osteoporotic fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of bone mineral density loss.
Visual Identification: White to off-white round uncoated tablets without any markings.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Registered
2018-04-03